Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Medtronic reaches glucose monitoring sensor milestone

Medtronic : 25 March, 2008  (Company News)
More than one million sensors of Medtronic’s continuous glucose monitoring (CGM) products have now been manufactured and sold.
The recipient of the milestone one millionth sensor was Tim Parker of San Jose, California. Parker, diagnosed with type 1 diabetes 11 years ago, has used CGM therapy for two years to help him manage his diabetes.

“Today we salute Tim, thousands of patients like him and all of the Medtronic employees who have contributed to the success of our CGM technology,” said Chris O’Connell, president of the Diabetes business at Medtronic. “Medtronic pioneered CGM 10 years ago, and this important milestone demonstrates our momentum and clear industry leadership in the exciting new field of continuous glucose monitoring.”

Parker relies on his Paradigm REAL­Time System, and says it is fundamental to managing his diabetes effectively. Prior to adopting integrated insulin pump and CGM therapy, Parker – like many people with diabetes – experienced unexplained blood glucose excursions that worried him.

“I would go to bed with my blood glucose levels at 110 and wake up at 220. What could be happening to my body while I was asleep?” said Parker. Motivated to keep his blood glucose in check, he began researching options and learned about Medtronic’s CGM products on the internet.

After receiving a prescription from his physician, Parker quickly experienced the value of having an integrated approach to his diabetes.

“When I first started using CGM, I was amazed at all the information I had at my fingertips. I could see how food, exercise and sleep affected my blood glucose levels day and night, which is something I wasn’t able to do before,” he recalled. “CGM gives me powerful information that allows me to take the right steps to better manage my diabetes, and provides alarms to help me avoid dangerous lows that I often cannot detect on my own.”

Medtronic has more than a decade of CGM experience, and is leading the technology revolution in diabetes care by providing patients with new levels of protection, confidence and freedom in managing their diabetes. The Paradigm REAL­Time Insulin Pump and Continuous Glucose Monitoring (CGM) System is the world’s first insulin pump with REAL­Time continuous glucose monitoring.

The Paradigm REAL­Time System has all of the benefits of CGM plus the added value of precise insulin delivery through the use of insulin pump therapy. The Guardian REAL­Time System is a stand­alone CGM device without insulin delivery. Both devices are available for adult patients as well as children ages seven to 17.

The Paradigm REAL­Time System relays glucose readings every five minutes from a glucose sensor to the insulin pump, which displays up to 288 readings a day – nearly 100 times more information than three daily fingersticks.

Glucose measurements obtained by the sensor are relayed every five minutes and displayed in three­hour and 24­hour trend graphs, as well as arrows to indicate how quickly glucose is moving up or down. To celebrate Parker’s receipt of the one millionth glucose sensor, he will receive an all­expenses­paid trip to Medtronic’s Diabetes facility located in Northridge, California, where he will tour the facility, meet the senior management and engineering teams and see the glucose sensor manufacturing process.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo